Evidence map›Paper›PMID 37838513›Full record

ArticleTrends in parasitology2023

Vaccines against tick-borne diseases: a big step forward?

Nathalie Boulanger, Stephen Wikel

Abstract readComment
PubMed Publisher
In one paragraph

Article in Trends in parasitology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Evolution of tick vaccinology.Parasitology · 2024
    Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Nathalie BoulangerFédération de Médecine Translationnelle - UR7290 : Early Bacterial Virulence: Group Borrelia, Université de Strasbourg, France; Centre National de Référence Borrelia, Centre Hospitalier Universitaire, Strasbourg, France. Electronic address: nboulanger@unistra.fr.
Stephen WikelDepartment of Medical Sciences, Frank H. Netter, M.D., School of Medicine, Quinnipiac University, Hamden, CT 06518, USA. Electronic address: stephen.wikel@quinnipiac.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ticks and tick-borne diseases are on the rise due to socioecosystemic changes and climate modification and are affecting human and animal health. Few vaccines are available. Two recent articles from Matias et al. and Pine et al. used mRNA technology to explore tick and pathogen proteins as vaccine candidates.

Indexed as

Tick-Borne DiseasesTicksVaccinesAnimalsHumansVaccinesacquired resistancehypersensitivityLyme vaccinetick salivatransmission-blocking vaccine

Identifiers

PMID37838513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.